GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pentixapharm Holding AG (XTER:PTP) » Definitions » Total Long-Term Liabilities

Pentixapharm Holding AG (XTER:PTP) Total Long-Term Liabilities : €3.93 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Pentixapharm Holding AG Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Pentixapharm Holding AG's Total Long-Term Liabilities for the quarter that ended in Dec. 2024 was €3.93 Mil.

Pentixapharm Holding AG Total Long-Term Liabilities Historical Data

The historical data trend for Pentixapharm Holding AG's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pentixapharm Holding AG Total Long-Term Liabilities Chart

Pentixapharm Holding AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
0.76 13.57 15.52 3.93

Pentixapharm Holding AG Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24
Total Long-Term Liabilities Get a 7-Day Free Trial 13.57 - 15.52 16.03 3.93

Pentixapharm Holding AG Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Pentixapharm Holding AG Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Pentixapharm Holding AG's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Pentixapharm Holding AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pentixapharm Holding AG (XTER:PTP) » Definitions » Total Long-Term Liabilities
Comparable Companies
WBO:MARI VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX SMMT RPRX OCSE:GMAB XKRX:196170 INCY HKSE:02269 INSM HKSE:01801 SHSE:603392
Traded in Other Exchanges
PTPN:Austria
Address
Robert-Rossle-Street 10, Berlin, DEU
Website
https://www.pentixapharm.com
Pentixapharm Holding AG is a clinical-stage biopharmaceutical company active in the field of research and development of radiopharmaceuticals for diagnostic and therapeutic applications. Radiopharmaceuticals are medical substances containing radioactive elements used in nuclear medicine to diagnose or treat diseases. Its clinical pipeline encompasses PentixaTher, a Yttrium-90 based therapeutic against non-Hodgkin lymphomas (NHL), and PentixaFor, a Gallium-68-based companion diagnostic.

Pentixapharm Holding AG Headlines

No Headlines